Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Glucagon and the Regulation of Carbohydrate Metabolism

Abstract

THERE is considerable experimental evidence that glucagon (hyperglycæmic factor of the pancreas) is a true hormone which originates in the α-cells of the islets of Langerhans1. Its isolation and crystallization were reported in 19532. The crystalline material appears to be a simple protein with a molecular weight of approximately 4,200 and an amino-acid content which differs significantly from that of insulin3. Minute doses of crystalline glucagon (0.1γ in the cat) cause a significant rise in blood sugar3. This effect is probably brought about by a stimulation of liver glycogenolysis, since glucagon has been shown to increase the net synthesis of liver phosphorylase4. Further than this, little is known about the action or physiological role of glucagon. Current speculation revolves about three possibilities: (a) that glucagon is an anti-insulin hormone1, (b) that it is an insulin synergist5, or (c) that it has no significant function in the control of carbohydrate metabolism6.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Foa, P., “Advances in Internal Medicine”, 6, 29 (Year Book Pub. Inc., Chicago, 1954). DeDuve, C., Lancet, ii, 99 (1953).

    Google Scholar 

  2. Staub, A., Sinn, L., and Behrens, O. K., Science, 117, 628 (1953).

    Article  ADS  CAS  Google Scholar 

  3. Staub, A., Sinn, L., and Behrens, O. K., J. Biol. Chem., 214, 619 (1955).

    CAS  PubMed  Google Scholar 

  4. Sutherland, E. W., and Cori, C. F., J. Biol. Chem., 188, 531 (1951). Sutherland, E. W., Wosilait, W. D., and Ball, T., Fed. Proc., 14, 289 (1955).

    CAS  PubMed  Google Scholar 

  5. Bürger, M., “Fortschritte der Diagnostik und Therapie”, Bd. 1, Heft 7 (1950).

  6. Conn, J. W., Ann. Int. Med., 38, 179 (1953).

    Article  CAS  Google Scholar 

  7. (a) Elrick, H., Hlad, C. J., Witten, T., J. Clin. Invest. (Dec. 1955). (b) Elrick, H., Hlad, C. J., Arai, Y., and Smith, A., J. Clin. Invest, (in the press).

  8. Nelson, N., J. Biol. Chem., 153, 375 (1944).

    CAS  Google Scholar 

  9. Elrick, H., International Symposium, Hypophyseal Growth Hormone Nature and Actions, 561 (McGraw-Hill Book Co., Inc., 1955).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

ELRICK, H. Glucagon and the Regulation of Carbohydrate Metabolism. Nature 177, 892–893 (1956). https://doi.org/10.1038/177892a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/177892a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing